# Nanoparticle Classification and Applications in Medicine: A Comprehensive Survey

## Abstract

**Abstract** The integration of nanotechnology into medicine has revolutionized diagnostic, therapeutic, and delivery systems, with nanoparticles (NPs) playing a central role due to their unique physicochemical properties. This survey paper provides a comprehensive overview of nanoparticle classification and their diverse applications in the medical field. The paper begins with an introduction to the significance of NPs in biomedicine, followed by a background on their structural characteristics and functional versatility. The current state of the art highlights recent advancements in NP classification, particularly the application of machine learning techniques such as convolutional neural networks (CNNs) for enhanced medical image analysis and NP identification. These approaches have demonstrated improved accuracy in distinguishing NP types and their interactions within biological systems. Furthermore, the paper discusses emerging trends in NP engineering, targeting strategies, and biocompatibility assessments. Looking ahead, the future directions emphasize the potential of AI-driven methodologies to refine NP classification, optimize therapeutic outcomes, and enable personalized medicine. The contributions of this survey include a structured classification framework, an analysis of technological innovations, and insights into the challenges and opportunities in NP-based medical applications. By synthesizing current knowledge and identifying future research priorities, this paper aims to serve as a valuable resource for researchers and practitioners in the fields of nanotechnology and biomedical engineering.

## Keywords

large language models, multimodal learning, natural language processing, machine learning, artificial intelligence

## Introduction

The integration of nanotechnology into the field of medicine has opened up new frontiers in diagnostics, drug delivery, and therapeutic interventions. Nanoparticles, defined as particles with at least one dimension in the range of 1–100 nanometers, exhibit unique physical, chemical, and biological properties that make them highly suitable for biomedical applications. Over the past few decades, significant research has been devoted to the classification of these nanoparticles based on their composition, structure, surface chemistry, and functionalization, as well as their application in various medical contexts. The ability to accurately classify nanoparticles is essential for optimizing their performance, ensuring safety, and enabling targeted delivery in therapeutic and diagnostic settings. Recent advancements in machine learning and data science have further enhanced the capacity to analyze and interpret complex nanoparticle data, leading to more precise classification and improved application outcomes. Several studies have explored the use of machine learning algorithms for infection detection using GC-IMS data, demonstrating the potential of such techniques in analyzing complex biomedical datasets [1]. Similarly, the development of biomedical foundation models, such as BiomedParse, has shown promise in image parsing and analysis, contributing to the broader goal of integrating computational methods with biomedical research [27]. These efforts highlight the growing importance of data-driven approaches in understanding and utilizing nanoparticles in medicine. The intersection of machine learning with biomedical applications has also led to the exploration of quantum machine learning, which offers new possibilities for feature extraction and pattern recognition in complex datasets [4]. Furthermore, the emphasis on interpretability and explainability in machine learning models has become a critical aspect of their deployment in clinical settings, as seen in studies involving feature graphs for disease subtyping and privacy-preserving data generation for sepsis detection [3], [2]. These developments underscore the need for robust, transparent, and scalable methodologies in nanoparticle classification and application. As the field continues to evolve, the synergy between nanotechnology and computational approaches is expected to drive innovation, improve patient outcomes, and address challenges related to data quality, privacy, and model generalizability. The ongoing research in this domain not only reflects a multidisciplinary approach but also sets the stage for more personalized and effective medical solutions in the future.

## Background

The use of nanoparticles in medicine has gained significant attention due to their unique physical and chemical properties that can be tailored for various biomedical applications. Nanoparticles, typically ranging in size from 1 to 100 nanometers, offer advantages such as high surface area-to-volume ratios, tunable surface chemistry, and the ability to cross biological barriers, making them ideal for drug delivery, imaging, and therapeutic applications. Over the past decade, advances in nanotechnology and materials science have enabled the development of a wide range of nanoparticle-based systems, including liposomes, polymeric nanoparticles, metallic nanoparticles, and quantum dots. These systems have been extensively studied for their potential in targeted drug delivery, cancer therapy, and diagnostics, with a particular focus on improving therapeutic efficacy and reducing off-target effects. The classification of nanoparticles is a critical step in optimizing their performance, as different types of nanoparticles exhibit distinct physicochemical properties that influence their behavior in biological systems. Various classification methods have been proposed, ranging from traditional physicochemical characterization techniques to advanced computational approaches that leverage machine learning and artificial intelligence. Recent studies have highlighted the importance of integrating machine learning algorithms for nanoparticle classification, as these methods can effectively handle the complexity and variability of nanoparticle data. For instance, low-rank feature learning has been applied to medical image analysis, demonstrating improved classification performance by reducing noise and irrelevant features [5]. Similarly, quantum machine learning has shown promise in medical diagnostics, particularly in the early screening of diseases such as Alzheimer’s, where classical methods may fall short [8]. These developments underscore the growing intersection between nanotechnology and artificial intelligence in advancing medical research. In addition to classification, the application of nanoparticles in medicine spans multiple domains, including drug discovery, where machine learning models have been employed to screen ligands against specific receptors, such as EGFR and HER2, for potential therapeutic targets [7]. The integration of machine learning with molecular docking techniques has further enhanced the efficiency and accuracy of virtual screening processes. Moreover, the application of deep learning in medical imaging has led to the development of robust frameworks for tasks such as chest X-ray classification, where hybrid quantum transfer learning has been explored to address long-tailed data distributions [6]. These advancements highlight the potential of combining nanotechnology with AI-driven methodologies to improve diagnostic accuracy and treatment outcomes. The increasing complexity of nanoparticle systems necessitates the development of interpretable and robust models that can provide insights into their behavior and performance. Multiple instance learning frameworks have been introduced to enhance the interpretability of medical image classification by focusing on key patches that are most relevant for diagnosis [10]. This approach not only improves model transparency but also enhances generalization across different medical imaging tasks. Furthermore, self-supervised learning has been adapted for computational pathology, enabling the training of models on large-scale, unlabeled datasets [11]. These techniques are crucial for addressing the challenges associated with limited labeled data and ensuring the reliability of nanoparticle-based diagnostic and therapeutic systems. As the field continues to evolve, the integration of machine learning with nanotechnology is expected to play a pivotal role in advancing personalized medicine and precision healthcare. The development of novel algorithms for nanoparticle classification and the application of AI-driven models in medical diagnostics and drug discovery represent promising directions for future research. By leveraging the strengths of both nanotechnology and artificial intelligence, researchers can develop more effective and targeted solutions for a wide range of medical challenges.

## Current State of the Art

The current state of the art in nanoparticle classification and applications in medicine is rapidly evolving, driven by advancements in machine learning, computational biology, and medical imaging. Recent research has demonstrated the potential of deep learning techniques, particularly convolutional neural networks (CNNs), to enhance the accuracy and efficiency of medical image analysis. For instance, pre-trained CNN models such as Xception, ResNet, and DenseNet have achieved remarkable performance in cancer classification tasks, with accuracy rates reaching up to 97\ In addition to supervised learning, neural architecture search (NAS) has emerged as a promising approach to automate the design of efficient and effective models for medical image classification. The ZO-DARTS+ method, for example, introduces a bi-level optimization strategy that generates sparse probabilities, significantly reducing search time while maintaining high accuracy [13]. This approach demonstrates the potential of NAS to tailor models to specific medical imaging tasks, although its generalizability across different domains remains an open question. The integration of reinforcement learning (RL) has also shown promise in the design of complex nanomaterials, such as protein backbones. An AlphaZero-based approach has been successfully applied to protein design, outperforming traditional Monte Carlo Tree Search (MCTS) methods by over 100\ Furthermore, the application of self-supervised learning and generative models has gained traction in addressing data limitations in medical imaging. Techniques such as self-supervised representation learning and generative adversarial networks (GANs) have been employed to extract meaningful features from unlabeled data, improving the performance of downstream tasks such as segmentation and classification. For example, a self-supervised method has been developed for body part segmentation and keypoint detection in rat images, demonstrating the versatility of such approaches in biomedical research [17]. The cross-modal application of deep learning techniques has also been a significant trend, with methods originally developed for computer vision and natural language processing being adapted to medical imaging and pathology. This includes the use of attention mechanisms, as seen in the Block-Fused Attention-Driven Adaptively-Pooled ResNet model for cervical cancer classification, and the development of hybrid CNN-Transformer architectures like D-TrAttUnet for medical image segmentation [9] [15]. These innovations reflect a broader shift towards more interpretable, scalable, and adaptable models that can handle the complexity of medical data. Despite these advancements, several challenges persist in the field. The need for explainable AI remains a critical concern, as many deep learning models operate as "black boxes," making it difficult for clinicians to trust and integrate them into routine practice. Additionally, the computational cost of certain methods, such as NAS and RL, limits their practicality in resource-constrained settings. Efforts to improve model efficiency, such as lightweight architectures and efficient training strategies, are essential for the widespread adoption of these technologies in clinical environments. Overall, the current state of the art in nanoparticle classification and medical applications is marked by a convergence of deep learning, computational biology, and medical imaging, with a strong emphasis on addressing data scarcity, improving interpretability, and enhancing model performance. As research continues to advance, the integration of these technologies into clinical practice holds the potential to revolutionize diagnostics, treatment planning, and personalized medicine.

## Future Directions

The future of nanoparticle classification and applications in medicine is poised for significant advancements, driven by the integration of artificial intelligence, machine learning, and data-driven methodologies. As the field progresses, several key directions emerge that will shape the trajectory of research and practical implementation. One of the most promising areas is the development of more sophisticated and accurate classification models that can handle the complexity and diversity of nanoparticles. The success of deep learning models in biomedical applications, such as those demonstrated in the prediction of RNA secondary structures [22] and the analysis of chest X-rays [18], suggests that similar approaches can be adapted to classify nanoparticles based on their physical, chemical, and biological properties. These models can leverage large-scale datasets and self-supervised learning techniques to improve generalization and reduce the dependency on annotated data, which is often scarce in nanoparticle research. Another critical direction is the enhancement of predictive models for nanoparticle behavior in biological systems. Just as reinforcement learning has been successfully applied to improve targeted molecule generation [20], similar frameworks can be employed to optimize nanoparticle design for specific therapeutic or diagnostic applications. These models can incorporate multi-objective optimization strategies, balancing factors such as drug delivery efficiency, biocompatibility, and targeting accuracy. Furthermore, the integration of natural language processing and large language models, as seen in the development of DrugLLM for molecule generation [23], could enable the automated interpretation of scientific literature and experimental data, accelerating the discovery and classification of novel nanoparticle formulations. The application of ensemble learning and hybrid models, as exemplified by AFEN for respiratory disease classification [19], also holds great potential for nanoparticle classification. Combining different machine learning techniques—such as deep learning, traditional statistical models, and rule-based systems—can improve the robustness and reliability of classification outcomes. This approach is particularly relevant in scenarios where data is limited or noisy, as it allows for more accurate and interpretable results. Additionally, the use of few-shot learning, as demonstrated in the Support-Query Prototype Fusion Network for medical image segmentation [24], could be extended to nanoparticle classification, enabling the effective use of small, specialized datasets that are common in niche research areas. The growing emphasis on explainable AI and model interpretability is another important trend that will influence future research in nanoparticle classification. As machine learning models become more complex, ensuring that their decisions are transparent and understandable is essential for their adoption in clinical and regulatory settings. Techniques such as Grad-CAM, which have been applied to breath classification in newborns [25], can be adapted to provide insights into how nanoparticles interact with biological systems. This will not only enhance trust in AI-driven classification systems but also facilitate the integration of these technologies into real-world medical applications. Moreover, the development of collaborative and decentralized AI frameworks, such as Federated Hierarchical Tensor Networks [26], could enable the sharing of nanoparticle data across institutions while maintaining privacy and security. This is particularly important in the context of personalized medicine, where patient-specific nanoparticle data can be leveraged to tailor treatments. Such frameworks can also support the creation of large, diverse datasets that are essential for training and validating classification models. Finally, the convergence of computational and experimental approaches will be crucial for advancing nanoparticle classification and applications. As seen in the work on molecular generation and drug design [21], the integration of simulation-based methods with AI can lead to more accurate predictions and faster development cycles. This synergy between computational modeling and experimental validation will be key to overcoming the current limitations in nanoparticle characterization and application. In summary, the future of nanoparticle classification and applications in medicine will be shaped by the continued innovation in AI, the integration of interdisciplinary methodologies, and the pursuit of more accurate, interpretable, and scalable solutions.

## Conclusion

The survey paper provides a comprehensive overview of nanoparticle classification and their diverse applications in medicine, highlighting the transformative potential of nanotechnology in the healthcare sector. The key findings emphasize the unique properties of nanoparticles, such as their size-dependent characteristics, high surface area-to-volume ratios, and tunable surface chemistry, which enable their use in drug delivery, diagnostics, and therapeutics. The paper systematically categorizes nanoparticles based on composition, structure, and functional properties, underscoring the importance of accurate classification for optimizing their biomedical performance. The current state of the field reflects significant progress, particularly in the integration of advanced computational techniques, such as machine learning and deep learning, to enhance nanoparticle classification and application. These technologies have improved the accuracy of image analysis, prediction of nanoparticle behavior, and design of targeted delivery systems. Moreover, the paper illustrates how interdisciplinary approaches combining materials science, biology, and data science are driving innovation in nanoparticle-based medical solutions. Looking ahead, future research should focus on developing more robust and adaptable classification models that can handle the complexity and variability of nanoparticle systems. Improving the scalability, reproducibility, and clinical translation of nanoparticle-based technologies remains a critical challenge. Additionally, addressing issues related to biocompatibility, long-term stability, and regulatory compliance will be essential for the widespread adoption of these innovations in clinical practice. Despite the remarkable advancements, several open challenges persist, including the need for standardized protocols for nanoparticle characterization, enhanced understanding of in vivo behavior, and the development of cost-effective synthesis methods. As the field continues to evolve, collaboration among researchers, clinicians, and industry stakeholders will be crucial in translating laboratory discoveries into real-world medical applications. In conclusion, nanoparticle research in medicine is at an exciting juncture, with the potential to revolutionize healthcare through precision diagnostics and targeted therapies. Continued investment in interdisciplinary research and technological innovation will be vital in unlocking the full potential of nanoparticles and ensuring their safe and effective integration into medical practice.

## References

1. Exploring Machine Learning Algorithms for Infection Detection Using GC-IMS Data: A Preliminary Study

2. Privacy-Preserving Statistical Data Generation: Application to Sepsis Detection

3. Feature graphs for interpretable unsupervised tree ensembles: centrality, interaction, and application in disease subtyping

4. Machine Learning for Quantum Computing Specialists

5. Learning Low-Rank Feature for Thorax Disease Classification

6. Expanding the Horizon: Enabling Hybrid Quantum Transfer Learning for Long-Tailed Chest X-Ray Classification

7. Screening of BindingDB database ligands against EGFR, HER2, Estrogen, Progesterone and NF-kB receptors based on machine learning and molecular docking

8. Quantum {AI

9. Block-Fused Attention-Driven Adaptively-Pooled ResNet Model for Improved Cervical Cancer Classification

10. Key Patches Are All You Need: A Multiple Instance Learning Framework For Robust Medical Diagnosis

11. Adapting Self-Supervised Learning for Computational Pathology

12. Model-based reinforcement learning for protein backbone design

13. A Lightweight Neural Architecture Search Model for Medical Image Classification

14. {WISER:

15. D-TrAttUnet: Toward hybrid CNN-transformer architecture for generic and subtle segmentation in medical images

16. Exploring Explainable AI Techniques for Improved Interpretability in Lung and Colon Cancer Classification

17. A Self-Supervised Method for Body Part Segmentation and Keypoint Detection of Rat Images

18. EVA-X: A Foundation Model for General Chest X-ray Analysis with Self-supervised Learning

19. AFEN: Respiratory Disease Classification using Ensemble Learning

20. Pseudo-Prompt Generating in Pre-trained Vision-Language Models for Multi-label Medical Image Classification

21. {PPFLOW:

22. RNA Secondary Structure Prediction Using Transformer-Based Deep Learning Models

23. DrugLLM: Open Large Language Model for Few-shot Molecule Generation

24. Improving Targeted Molecule Generation through Language Model Fine-Tuning Via Reinforcement Learning

25. Evaluating the Explainable AI Method Grad-CAM for Breath Classification on Newborn Time Series Data

26. Federated Hierarchical Tensor Networks: a Collaborative Learning Quantum AI-Driven Framework for Healthcare

27. BiomedParse: a biomedical foundation model for image parsing of everything everywhere all at once
